Related by context. Frequent words. (Click for all words.) 63 Biologics License Application BLA 62 Biologics License Application 62 sBLA 61 Marketing Authorization Application 60 confirmatory Phase III 60 alogliptin 60 Marketing Authorization Application MAA 59 FavId 58 MOZOBIL 58 SILENOR TM 57 NDA submission 57 Complete Response letter 57 palifosfamide 57 sNDA 57 refractory Hodgkin lymphoma 57 SinuNase 56 pivotal Phase III 56 PREOS 56 Marqibo 56 ThermoDox ® 56 L MTP PE 56 Complete Response 56 pralatrexate 56 CoFactor 56 Phase III pivotal 56 Phase III 55 AP# [003] 55 maribavir 55 phase 2a 55 phase IIa 55 romidepsin 55 tesmilifene 55 Pixantrone 55 Phase 2b clinical 55 Phase Ib 55 TREANDA 55 Phase IIb trial 54 Phase 2b study 54 Board DSMB 54 pixantrone 54 OFIRMEV 54 Topical Interferon Alpha 2b 54 Neuradiab 54 PROPEL trial 54 Phase 2b trial 54 Genasense 54 Phenoptin 54 New Drug Application 54 Acetavance 54 pivotal Phase 54 alvimopan 54 ADVEXIN 54 Phase IIa trial 54 TOCOSOL Paclitaxel 54 tezampanel 54 Phase 1b 54 Research CDER 54 Phase 1b trial 54 Fast Track Designation 53 Orphan Drug status 53 methylnaltrexone 53 phase IIb 53 Phase II 53 orphan designation 53 Phase III clinical 53 Phase 1b clinical 53 talactoferrin 53 Zenvia 53 clofarabine 53 axitinib 53 INDs 53 Act PDUFA date 53 Phase IIa clinical trials 53 Vilazodone 53 Phase 2a clinical 53 Phase 2a 53 Phase 2a trial 53 randomized Phase III 53 bazedoxifene 53 Icatibant 53 confirmatory Phase 3 53 Restanza 52 TELCYTA 52 ofatumumab 52 Mozobil 52 pharmacokinetic studies 52 ridaforolimus 52 pegloticase 52 NUVIGIL 52 Fast Track designation 52 Ceplene 52 Phase III trials 52 PXD# 52 Zerenex 52 TORISEL 52 Approvable Letter 52 clinical endpoints 52 thymalfasin 52 Phase IIb clinical 52 nab paclitaxel 52 resubmission